Tue, Mar 3, 2015, 3:31 PM EST - U.S. Markets close in 29 mins.

Recent

% | $
Quotes you view appear here for quick access.

Starbucks Corporation Message Board

antisense_science 21 posts  |  Last Activity: Feb 27, 2015 9:12 AM Member since: Oct 24, 2003
  • I am wondering if any "Inflection" - did I miss it already? LOL
    Try again Paul? Sorry most investors did not share your enthusiasm the last time around or did it fall on deaf ears?
    Pl. try again - something to wake this up or better yet - wake everyone up on your board and do something for the free money you are earning every year at the cost of the shareholders.

  • Reply to

    About Oncosil and relationship with Psivida

    by terry290737 Feb 25, 2015 6:54 AM
    antisense_science antisense_science Feb 27, 2015 9:07 AM Flag

    You have no clue what you are talking about. Oncosil has no relationship with pSivida - the technology was sold for a song and the CEO danced for $100K. Stop talking about OnCoSil.

  • Reply to

    Retisert

    by ruraddy Feb 24, 2015 12:49 PM
    antisense_science antisense_science Feb 25, 2015 5:42 PM Flag

    Much better AIDS cocktails have basically made the drug unnecessary. Isis Pharm also had a similar drug (Vitravene) which became irrelevant. Back in those days the fight was between Vitravene and Vitrasert. I have been invested in Isis for a very long time and pSivida for about 2 years now - still watching the paint dry so to speak.
    Neither of them made significant money in the long run thanks to better drugs available for AIDS patients which helped control the immune system better avoiding the need to a surgery every 8-10 months for Vitrasert.

  • Reply to

    Oh they are moving their HQ

    by lefty_rosenthal7 Feb 12, 2015 11:32 PM
    antisense_science antisense_science Feb 13, 2015 8:28 AM Flag

    It is a good thing they are thinking of conserving money.
    What happened to the Teva partnership dissolution agreement by Jan? How much money could they squeeze out of Teva?

  • Reply to

    The Most Broad CC Ever

    by mickmack50 Feb 5, 2015 8:59 PM
    antisense_science antisense_science Feb 6, 2015 9:13 AM Flag

    Anyone know how far along is Durasert trial? Is it enrolling, completed, continuing, discontinued? Nothing on clinicaltrials.gov. Just curious. When is PFE taking over the development if at all? What is the milestone payment if they do take over PIII? Or is PFE even interested and if not what happens to that program?
    Much hype about OA - unfortunately it is years away- nice to have but too far out for any material benefit. A steroid shot helps for about 1-3 months so how long is this pre-clinical trial going to take place before they decide it will work. I have had doubts about OA only because it is a bone-on-bone disease due to lack of cartilage or depletion. How does a nano silicon tube or structure not get crushed in the joint? I am not too excited about the opportunity, it would be nice to have but the challenges are too many. Analysts on the call never ask the tough questions so you do not get any "doubters" who can help clear the air.

  • antisense_science antisense_science Feb 5, 2015 7:30 PM Flag

    Yes, you are right aren't you? Read the Qtrly report yet Losses attributable to increased expenses and stock based compensation. I have no problems giving the employees stock options, the CEO and BOD on the other hand do get exceptional health care and other benefits, handsome salaries and they are not performing so there should be no "stock based comp. to the BOD or CEO". Still what comes out of my mouth is critical of the mgmt and it will remain so until they REALLY start to work for the shareholders interest. BOD is not for the benefit of the CEO, they are the custodians of the Co. they need to ensure the CEO is doing what is required for the shareholders and the Co. Never happens.....

    Too bad people on this board want to misread me... their loss. I am long and I have a lot at stake and am #$%$ about giving stock options to the management for not delivering. $25M in milestone payment is all they can keep repeating - it is getting old. Some one on the board is unhappy about Yahoo not showing the "actual" cash on hand - too bad yahoo does not update - does it really matter? Everyone who know the Co. knows what it has, anyone who wants to buy the stock should do some reading even if it is this silly message board. Anyone who looks at Yahoo only and stays away - good riddance. Nothing lost, if the guy does not buy 200 shares of PSDV nothing will change.

  • antisense_science antisense_science Feb 4, 2015 10:19 PM Flag

    Stock is still $4 or around so free $4 is better than nothing which is ON TOP OF HIGH SALARY, BONUSES AND OTHER PERKS. GO LICK SOME MGMT OR TOUCH YOURSELF.

  • It does not help anyone. Stick to the facts and what you know.
    Co. has decent products, and a good product pipeline (if you believe the mgmt). Cash on hand is sufficient to carry the operations through 2016 and maybe to 2017.
    Revenue from ALIM is going to continue to be substandard - you could get a surprise in 2016 Q3-Q4 possible.
    Tethadur licensing is the only hope for the investors. If the Mgmt funks that up it will be goodbye adios amigos to this stock and stock holders. Based on what the management has done to date is made false promises and not delivered, while pocketing free shares from the shareholders at every opportunity.

    So - stop the hype - wait and see what this lame horse #$%$ management does and take it from there. They like every other BOD/CEO combo listed in USA are out to rob the shareholders and employees blind, they do not care about anyone but themselves. Their freebies, position and power is all that matters to them. IR woman can only say what she can say - read between the lines when you do talk to her. There is no funking catalyst that can save the longs - stop wishing for a stupid buy out. Who would seriously want to buy this out unless Tethadur is working and near the goal line - the way these farts are operating it will be 2020 before they have (20/20) vision on possibility of bringing it to market.

  • Still think PSDV is too cheap and you are the only genius in town to figure that out?
    When a stock is cheap, it is cheap for a reason. Not every stone is a diamond in the rough and this is turning out to be worthless piece of coal.

    Hey Paul step down and take your buddies on the board with you, so the shareholders can anticipate the Mgmt to do something positive with the technology besides false promises - You Paul are an under achiever and have been over promising for a very long time - still need freebie shares for you and your buddies on the BOD? Rascals.

  • Reply to

    Will US Iluvien Launch Move The Needle

    by mickmack50 Jan 14, 2015 10:34 AM
    antisense_science antisense_science Jan 20, 2015 7:50 AM Flag

    Are you stupid? BIIB at $200 would be a great buying opportunity just as you think PSDV is at $4 - the example is to show the lack of buying interest in the stock implies no one things it is grossly undervalued at $4.
    You really think you are a genius?

  • Reply to

    Will US Iluvien Launch Move The Needle

    by mickmack50 Jan 14, 2015 10:34 AM
    antisense_science antisense_science Jan 19, 2015 2:57 PM Flag

    Let us look at some facts- this Co. has cash for 1 year? May be 2 at tops. No product likely on the market in 2 yrs. ALIM contribution is going to be negligible at best.
    Licensing deals are likely - but Mgmt is sleeping on Tethadur - the technology is overly hyped and management keeps under delivering. Issues were not brought to shareholder attention - at best the technology is delayed by 2-3 yrs. As the management who is interested in partnering and where are the licenses? Eventually the technology will be sold for a song and a prayer?
    I do not care about what you think of my credibility - I have stated the same things for nearly a year. Show me some contracts/licensing deals or $4 is too high to justify the ALIM contribution. For my credibility the St. agrees with me - the stock is at $4 for a reason- you think you are a genius to find a diamond in the rough and found this Co. unnoticed for $4? How many hedge fund and mutual funds and money managers make a living researching and investing in biotech Cos? How come no one seems to agree with you because I do not see a like of interested buyers bidding the stock up - 53K shares traded in a day at $4 implies there is no interest.
    You can confuse the lack of interest with general market conditions etc. What do you think the buying interest would be if BIIB were to trade at $200? You are joke if you think you found something no one in the world noticed.Go back and keep searching for positives about PSDV and report everything you find. In the meantime hope for the stock price to move based on what #$%$ you write here.
    For me, I will keep trying to expose Paul A and his cohourts with the hope they do something positive and/or wake up drunken investors like you and collectively demand Paul A to resign if he cannot show results in a few months. Enough is enough.

  • Reply to

    Will US Iluvien Launch Move The Needle

    by mickmack50 Jan 14, 2015 10:34 AM
    antisense_science antisense_science Jan 18, 2015 7:56 PM Flag

    People on this board need to stop thinking whatif senarios etc.... the stock price and volume says it all.
    Sorry to disappoint but would you rather wait a year before realizing this is junk unless the management wakes up and starts to act in the best interest of the shareholders. Not their own.

  • antisense_science antisense_science Jan 6, 2015 7:34 AM Flag

    Unfortunately no one will read anything in this news, except for longs who are desperately seeking something that will prop this stock up. No tradeable information in the story.
    Go back to the drawing board and chalk up something else now....

    Sentiment: Hold

  • antisense_science antisense_science Jan 5, 2015 8:48 AM Flag

    Good story, I am happy for the patient. Great work by everyone involved. Positive vibes...

    Sentiment: Hold

  • Reply to

    Medidur

    by madetotroll Dec 24, 2014 7:17 AM
    antisense_science antisense_science Dec 28, 2014 11:11 AM Flag

    I agree, one of us cannot make a dent, but a 100 of us can make a dent and hope for a change in the BOD. You are not really as helpless as you seem.....

    Sentiment: Hold

  • Reply to

    Medidur

    by madetotroll Dec 24, 2014 7:17 AM
    antisense_science antisense_science Dec 24, 2014 1:04 PM Flag

    No. I am not sitting and hoping the mgmt throws me a bone. I am vocal about the real issues that is keeping a lid on this stock and Co. Mgmt incompetency is the biggest issue there is and to top it up they keep giving themselves a pat on their own backs and steal more shares from the investors. Unlike you I will be in their faces everyday if required. That is the difference between sorry longs like you and me.
    You buy into every pitch these guys throw at you, I question everything because the track records show they are not working in the interest of the shareholders.
    Co. has promise so I am here, but I would want the mgmt to steal the Co. and its shareholders blind.

  • Reply to

    Medidur

    by madetotroll Dec 24, 2014 7:17 AM
    antisense_science antisense_science Dec 24, 2014 9:35 AM Flag

    Miniscule - the market is about 10% of Iluvien

    Paul gave himself and his board of cronies a really good Xmas bonus while the long shareholders like us are still holding the bag.

    Ya - I know the sorry longs on this board will say dump your shares... then need to clear their heads of the #$%$ Paul has been smoking up their heads....

  • Reply to

    someone with IBS

    by gswkool Dec 15, 2014 1:56 PM
    antisense_science antisense_science Dec 16, 2014 11:56 AM Flag

    it is the insiders dumping newly acquired shares.

    Sentiment: Hold

  • Reply to

    Where is the Xmas gift investors expect?

    by antisense_science Dec 12, 2014 7:12 AM
    antisense_science antisense_science Dec 12, 2014 2:35 PM Flag

    Does it take 2 yrs to slide a one liner in a presentation recently where he causally mentions there was some issue related to the injection needle blockage by the psi material? Sorry it is pathetic. Do not tell me, they have not known this for a long time. Anyone catch that blockage line in his pathetic presentation?

    Sentiment: Hold

  • Reply to

    Where is the Xmas gift investors expect?

    by antisense_science Dec 12, 2014 7:12 AM
    antisense_science antisense_science Dec 12, 2014 10:13 AM Flag

    Are you a paid pumper or just waiting for the crumbs the mgmt leaves you behind? Or are you Bev? Either ways I do not care. You think 125M i big deal? Can you do the math and tell me how many free shares or nearly free shares did the mgmt get in the past 10 years you have been holding this bag and how many of those shares the mgmt still owns?
    Who is the loser? I give and gave the mgmt enough rope now it is time to call the hangman.
    At some point the shareholders (us) need to start making a little noise.
    How many shares do you have BTW - you pumper? I have just under 1% of float - and yes I am #$%$ at the incompetence.
    So #$%$ if you cannot handle the management being bashed here. If I were to see the Mgmt face to face I would have the same things to tell them.

    And No. I will not sell, I will keep posting and keep writing to Bev and the Mgmt because they are not leveling with the shareholders. They cannot make presentations in middle of 2013 and claim they should have pre-clinical study results (as expected by an avg. investor in about 6 months), this has taken nearly 2 years and they have nothing to show for it.
    Paul made one passing statement about the needle and the material clogging the needle in his last presentation. Seriously, they need to man up and tell us what the f is going on.

    Sentiment: Hold

SBUX
94.07-0.15(-0.16%)3:31 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.